Global Health Ltd (Medanta) IPO gets 30% anchor allocated

The anchor issue of Global Health Ltd (Medanta) saw a robust response on 02nd November 2022 with 30% of the IPO size getting absorbed by the anchors. Out of the 6,56,41,952 shares on offer, the anchors picked up 1,96,92,584 shares accounting for 30% of the total IPO size. The anchor placement reporting was made to the BSE late on Wednesday. The IPO of Global Health Ltd (Medanta) opens on 03rd November 2022 in the price band of Rs.319 to Rs.336 and will close for subscription on 07th November 2022 (both days inclusive). The entire anchor allocation was made at the upper price band of Rs336. Let us focus on the anchor allotment portion ahead of the Global Health Ltd (Medanta) IPO.

Before we go into the details of the actual anchor allotment, a quick word on the process of anchor placement. The anchor placement ahead of an IPO/FPO is different from a pre-IPO placement in that the anchor allocation has a lock-in period of just one month, although under the new rules, part of the anchor portion will be locked in for 3 months. It is just to give confidence to investors that the issue is backed by large established institutions. 

However, the anchor investors cannot be allotted shares at a discount to the IPO price. This is explicitly stated in the SEBI revised regulations as under, “As per the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018, as amended, in case the Offer Price discovered through book building process is higher than the Anchor Investor Allocation Price, then the Anchor investors will be required to pay the difference by the pay-in as specified in the revised CAN.

An anchor investor in an IPO is normally a qualified institutional buyer (QIB) like a foreign portfolio investor or mutual fund or insurance company or a sovereign fund which invests before the IPO is made available to the public as per SEBI regulations. Anchor portion is part of the public issue, so the IPO portion to the public (QIB portion) is reduced to that extent. As initial investors, these anchors make the IPO process more attractive for investors, and instil confidence in them. Anchor investors also largely aid in price discovery of the IPO

Anchor placement story of Global Health Ltd (Medanta)

On 02nd November  2022, Global Health Ltd (Medanta) completed the bidding for its anchor allocation. There was an enthusiastic response as the anchor investors participated through the process of book building. A total of 1,96,92,584 shares were allotted to a total of 52 anchor investors. The allocation was done at the upper IPO price band of Rs.336 which resulted in an overall allocation of Rs.661.67 crore. The anchors have already absorbed 30% of the total issue size of Rs2,205.57 crore, which is indicative of the robust institutional demand. 

Listed below are the 16 anchor investors who got allotted at least 2.8% of the total anchor allocation individually. The entire anchor allocation of Rs.661.67 crore was spread across these 52 major anchor investors.

Data Source: BSE Filings

While the GMP has remained stable between Rs30 and Rs33, it shows an attractive but relatively subdued premium of 9-10% on listing. This has led to reasonable anchor response with the anchors taking in 30% of the total issue size. The QIB portion in the IPO will be reduced to the extent of the anchor placement done above. Only the balance amount will be available for QIB allocation as part of the regular IPO.

The general norm is that, in anchor placements, smaller issues find it hard to get FPIs interested while larger issues do not interest mutual funds. Global Health Ltd (Medanta) has been a mix, getting good response from FPIs and domestic mutual funds. The number and spread of the Foreign Portfolio Investors has been quite phenomenal in this case. With strong SIP flows, most equity funds are flush with cash at this point of time and that has helped the MF appetite for anchor allocation in this IPO of Global Health Ltd (Medanta).

Out of the total 1,96,92,584 shares allotted by way of anchor placement, Global Health Ltd (Medanta) allotted a total of 76,95,465 shares to 28 domestic mutual fund schemes across 13 AMCs. The mutual fund allocation represents 39.08% of the overall anchor allocation.